Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Pacific Biosciences (PACB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Innovative Biotech Companies Pushing the Envelope

FN Media Group Presents Microcapspeculators.com News Commentary

EBIO : 3.29 (+24.15%)
PACB : 3.40 (+2.10%)
VVUS : 0.84 (+2.32%)
PPCB : 0.0650 (-3.85%)
ATHX : 2.32 (-0.43%)
Pacific Biosciences to Gain From New Genome Sequencing Tools

Pacific Biosciences' (PACB) new multiplexing kit to make genome sequencing faster and cost-effective.

PACB : 3.40 (+2.10%)
ABMD : 443.58 (+0.66%)
ILMN : 288.75 (-0.49%)
TMO : 215.80 (-0.35%)
Pacific Biosciences Launches Microbial Multiplexing Kit, New SMRT Grant Program

Pacific Biosciences of California Inc., (Nasdaq:PACB) today announced that obtaining microbial genomes with high accuracy and contiguity has become faster and more affordable thanks to new multiplexing...

PACB : 3.40 (+2.10%)
Wellcome Sanger Institute Sequences Reference Genomes of 3,000 Dangerous Bacteria

The genomes of more than 3,000 bacteria, including some of the world's most dangerous, have been sequenced by researchers at the Wellcome Sanger Institute in collaboration with Pacific Biosciences (PacBio)....

PACB : 3.40 (+2.10%)
Why Is Pacific Biosciences (PACB) Down 6.7% Since its Last Earnings Report?

Pacific Biosciences (PACB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

PACB : 3.40 (+2.10%)
Pacific Biosciences Announces Favorable Outcome in UK and German Patent Litigation Against Oxford Nanopore

Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leader in long-read, high-resolution sequencing, today announced that it has entered into a five-year settlement agreement with Oxford Nanopore...

PACB : 3.40 (+2.10%)
Pacific Biosciences (PACB) Loss Wider Than Expected in Q1

Pacific Biosciences (PACB) Q1 earnings and revenues miss estimates; Sequel orders rise.

CHE : 323.68 (-0.91%)
PACB : 3.40 (+2.10%)
BAX : 75.22 (-0.25%)
ISRG : 490.49 (-1.02%)
Pacific Biosciences of California, Inc. Announces First Quarter 2018 Financial Results

Pacific Biosciences of California, Inc. (NASDAQ:PACB) today announced financial results for its first quarter ended March 31, 2018.

PACB : 3.40 (+2.10%)
Factors of Influence in 2018, Key Indicators and Opportunity within Bottomline Technologies, SkyWest, Pacific Biosciences of California, Argos Therapeutics, Luminex, and Fiserv -- New Research Emphasizes Economic Growth

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Bottomline Technologies, Inc....

SKYW : 57.20 (+1.69%)
EPAY : 48.50 (-1.42%)
ARGS : 0.1800 (+5.26%)
PACB : 3.40 (+2.10%)
FISV : 76.49 (+0.08%)
LMNX : 30.12 (-0.89%)
GENEWIZ And Pacific Biosciences Announce Winner Of The 2017 Structural Variant SMRT® Grant Program

Pacific Biosciences of California, Inc. (NASDAQ: PACB), the leader in long-read, high-resolution sequencing, and GENEWIZ, a leading global genomics service provider, are pleased to announce that Professor...

PACB : 3.40 (+2.10%)
Can Core Unit Drive Pacific Biosciences' (PACB) Q1 Earnings?

Pacific Biosciences gains ground on solid Sequel Growth, while shrinking service revenues raise concern.

HOLX : 40.43 (+0.50%)
EW : 152.51 (+0.63%)
SYK : 168.38 (-0.22%)
PACB : 3.40 (+2.10%)
Pacific Biosciences Gains as HudsonAlpha Picks Sequel System

Pacific Biosciences (PACB) sees increasing use of Sequel Sequencing System in pediatric and plant biologic case studies.

BHVN : 40.87 (+3.08%)
PACB : 3.40 (+2.10%)
BIO : 303.88 (+0.06%)
EVHC : 44.67 (-0.25%)
Pacific Biosciences Announces Ten-Unit Sequel System Order for Annoroad

Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leader in long-read, high-resolution sequencing, today announced a purchase order for 10 PacBio Sequel Systems that are expected to be installed...

PACB : 3.40 (+2.10%)
Pacific Biosciences Prevails in Patent Eligibility Ruling Against Oxford Nanopore

Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leader in long-read, high-resolution sequencing, today announced that Judge Leonard P. Stark of the U.S. District Court for the District of Delaware...

PACB : 3.40 (+2.10%)
What's Happening with These Biotech Stocks? -- OncoSec Medical, OvaScience, Pacific Biosciences of California, and Pieris Pharma

WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on ONCS, OVAS, PACB, and PIRS which can be accessed for free by signing up to www.wallstequities.com/registration....

PACB : 3.40 (+2.10%)
ONCS : 1.46 (+2.10%)
OVAS : 0.94 (unch)
PIRS : 5.17 (-2.82%)
Pacific Biosciences Announces Issuance of U.S. Patent for Concatemer Sequencing

Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leader in long-read, high-resolution sequencing, today announced that the U.S. Patent and Trademark Office ("USPTO") has issued U.S. Patent No....

PACB : 3.40 (+2.10%)
Pacific Biosciences Unveils New Version of Sequel Software

Pacific Biosciences (PACB) enhances performance and cost-effectiveness of the Sequel System.

PACB : 3.40 (+2.10%)
ATHN : 158.44 (+0.50%)
BIO : 303.88 (+0.06%)
PKI : 77.84 (-0.64%)
Pacific Biosciences (PACB) Down 15.6% Since Earnings Report: Can It Rebound?

Pacific Biosciences (PACB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

PACB : 3.40 (+2.10%)
Analysis: Positioning to Benefit within ADTRAN, NN, Sparton, Allete, The Ultimate Software Group, and Pacific Biosciences of California -- Research Highlights Growth, Revenue, and Consolidated Results

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ADTRAN, Inc. (NASDAQ:ADTN),...

ADTN : 15.45 (+1.98%)
NNBR : 21.50 (-0.69%)
SPA : 19.17 (+0.31%)
PACB : 3.40 (+2.10%)
ALE : 73.11 (+0.43%)
ULTI : 279.98 (+1.59%)
Are Options Traders Betting on a Big Move in Pacific Biosciences (PACB) Stock?

Surging implied volatility makes Pacific Biosciences (PACB) stock lucrative to the option traders.

PACB : 3.40 (+2.10%)

Van Meerten Stock Picks

5 Great Large Caps
This morning I wanted to find 5 Large Cap stocks that had performed well over the last year and still appeared to have some juice left in them.
ABMD +2.93 , NFLX -0.89 , VLO -1.64 , RL +0.62 , ALGN -3.61
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.
Free Commodities Newsletter

Get prepared for your trading day with

Barchart's Commodity Futures Morning Update Email

InsideFutures Commentary

InsideFutures weekly newsletter features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Friday morning to your inbox.

Agricharts Market Commentary

Today's Commentary

Corn futures closed with most nearby contracts 1 to 2 cents lower on Friday, despite showing gains at midday. Front month July lost 4.37% on the week. December fell to within 1 1/4 cents of the life of contract low in the overnight session. Managed m...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar